Immatics presenting at the 3rd Gene and Cell Therapy Summit 2021
Oct 06 - Oct 07, 2021
Join Immatics at the 3rd Gene and Cell Therapy: Quality Developments to Commercialization Online Summit! Addressing cellular and gene therapy-related developments and manufacturing controls, cell and gene therapies experts and advisers will exchange practical insights and expectation.
Wednesday October 6, 5:35pm - 6:00pm CEST
Presentation: Optimizing manufacturing and logistics for autologous ex vivo T-cell therapies
- Development of TCR-based immunotherapies against novel targets for solid tumours
- Manufacturing, supply chain and logistics during early-stage clinical development for TCR-engineered T-cell products
- Outlook towards late-stage development and commercialization
Presenter: Pinar Cicalese, Director CMC Commercial Strategy Immatics
We are looking forward to (e-)meeting you!
For more information please visit the event's website: 3rd Gene and Cell Therapy: Quality Developments to Commercialization Online Summit